| 摘要: |
| 结直肠癌(colorectal cancer,CRC)是全球第三大恶性肿瘤,结直肠癌肝转移(colorectal liver metastases,CRLM)是中晚期 CRC 患者死亡的首要原因。细胞外基质(extracellular matrix,ECM)是肿瘤微环境的高度活性成分,其通过信号传导不断影响肿瘤细胞的增殖、迁移、侵袭、免疫逃逸及治疗抵抗等。ECM的异常与失调与CRC肝转移进程及患者治疗反应高度相关。因此,干预ECM形成可能是阻断CRLM发生发展的重要策略。本文聚焦于ECM在CRLM中的作用,并综述靶向ECM治疗CRLM的最新进展,旨在为临床CRLM的预防与综合治疗提供新的研究思路。 |
| 关键词: 结直肠癌肝转移 细胞外基质 基质硬度 肿瘤细胞 抗肿瘤治疗 |
| DOI:10.13506/j.cnki.jpr.2025.07.012 |
| 基金项目:国家自然科学基金项目(No.82273329、32470989、82304551) |
|
|
|
| Research progress on the role of extracellular matrix in liver metastasis of colorectal cancer and targeted therapy |
| DA Huijuan1,CAO Qiuhua2,GAO Xinghua2 |
| (1.State Key Laboratory of Nature Medicines, China Pharmaceutical University, Nanjing 211198, China;2.School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing 211198, China) |
| Abstract: |
| Colorectal cancer (CRC) is the third largest malignant tumor in the world, and colorectal liver metastases (CRLM) are the primary cause of death in patients with middle and advanced CRC. The extracellular matrix (ECM) is a highly active component of the tumor microenvironment, which continuously influences the proliferation, migration, invasion, immune escape and therapeutic resistance of tumor cells through signal transduction. The abnormalities and dysregulation of ECM are highly correlated with the liver metastasis process of CRC and the treatment response of patients. Therefore, intervention in ECM formation may be an important strategy to block the occurrence and development of CRLM. This article focuses on the role of ECM in CRLM, and reviews the latest progress of targeting ECM in the treatment of CRLM, aiming to provide a new research idea for the prevention and comprehensive treatment of CRLM. |
| Key words: Colorectal liver metastases Extracellular matrix Matrix stiffness Tumor cells Anti-tumor therapy |